Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

What Fat Does to Arthritis

Ulf Müller-Ladner, MD, Klaus W. Frommer, PhD, and Elena Neumann, PhD  |  Issue: August 2011  |  August 1, 2011

Among other adipokines, resistin has been found in mice as a protein involved in adipocyte differentiation. Human resistin, on the other hand, increases the secretion of proinflammatory cytokines such as TNF, IL-6, and IL‑12, activates endothelial cells and increases endothelin-1 and several adhesion molecules as well as chemokines in these cells.6 Visfatin/pre–B cell colony enhancing factor (PBEF) is also called Nampt because of its nicotinamide phosphoribosyltransferase (NAmPRTase) activity. This molecule is involved in the synthesis of nicotinamide adenine dinucleotide, an essential co-factor of cell metabolism; in addition, it can activate human leukocytes and induces costimulatory molecules on the cell surface. In monocytes, visfatin/PBEF can stimulate the synthesis of proinflammatory cytokines such as IL‑1, TNF, and IL-6, and protects fibroblasts and neutrophils from apoptosis.7

So, how do adipokines influence the course of a chronic rheumatic disease such as rheumatoid arthritis (RA)? Given that levels of adiponectin in synovial fluid and serum are high and are related to joint destruction and long-term disease, these molecules would be expected to have an important role.8 Although articular “fat” is also found around an inflamed joint, the truly important finding on the role of adipokines in pathogenesis of RA related to local expression of adiponectin in joint tissue, including in the lining layer, perivascular area, and in several cells in the sublining (see Figure 1, above); adiponectin expression was also found at sites of cartilage destruction, synovial angiogenesis, and inflammation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Regarding a role in pathogenesis, adiponectin itself can boost joint-destructive RA synovial fibroblasts to full power by inducing synthesis of proinflammatory cytokines such as IL-6, a variety of chemokines, proangiogenic factors such as vascular endothelial growth factor, and matrix-degrading proteins including collagenases.9,10 This pathway appears to be independent of the known TNF routes because TNF and IL-1 could not be induced by adiponectin in RA synovial fibroblasts. The pluripotency of adiponectin was further illustrated by a similar effect on the rest of the “damaging orchestra of cells” in the rheumatoid joint. These cells, which play both loud and out of tune, include endothelial cells, chondrocytes, and lymphocyte subpopulations.

Figure 1: Strong expression of adiponectin.
Figure 1: Strong expression of adiponectin (in red) in the synovial lining, mesenchymal cells of the sublining, and perivascularly in a highly inflamed rheumatoid synovial tissue.

Table 1: Proinflammatory molecules released from adipose tissue.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
click for large version
Table 1: Proinflammatory molecules released from adipose tissue.1

Table 2: Key properties of adipokines in rheumatic diseases, especially RA.

click for large version
Table 2: Key properties of adipokines in rheumatic diseases, especially RA.1

Evolving Picture of Adipokine Action

Things are never as simple or easy as they first appear, however. As shown in subsequent studies, it has become obvious that human adiponectin consists of different isoforms and that glycosylation and oligomerization, which differ between species, are very important for the resulting functional effects of adiponectin.10,11 Because most experiments and animal models are performed using a “wild-type” mix containing different amounts of the respective isoforms, it is not yet possible to fully determine which isoforms are dominant in RA synovial tissue at sites of cartilage degradation and inflammation.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Adipokinesadipose tissueArthritisinflammatory connective tissuejoint diseasePathogenesis

Related Articles

    A&R Abstracts – ADIPOKINES

    August 1, 2011

    For Further Reading

    Decode the Crosstalk Between Bones, Brain, and Fat

    April 1, 2010

    Leptin inhibits serotonin synthesis in the neurons of the brainstem

    Researchers Probe the Role of Fat Cells in Inflammation

    September 20, 2018

    AMSTERDAM—It’s been many years since adipose tissue came to be appreciated not just as a store of energy, but also as a regulator of metabolism and an important player in immune function. Rheumatology researchers continue to drill down into the role of fat cells in the search for mechanisms that could reveal targets for the…

    Gout, Glucose Metabolism and Obesity: A Case Review

    November 2, 2014

    New research explores association between hyperurecimia and gout with metabolic derangement

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences